Tag: ADC

Latest News

ADC Therapeutics organise une conférence téléphonique sur les données des essais cliniques du Loncastuximab Tésirine (Lonca) à présenter au congrès annuel virtuel de l’Association européenne d’hématologie

Newsemia
LAUSANNE, Suisse–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE:ADCT), une société de biotechnologie spécialisée dans l’oncologie au stade clinique avancé, pionnière du développement et de la commercialisation de...
Cardiology

MRI of Reperfused Acute Myocardial Infarction Edema: ADC Quantification versus T1 and T2 Mapping.

Newsemia
Related Articles MRI of Reperfused Acute Myocardial Infarction Edema: ADC Quantification versus T1 and T2 Mapping. Radiology. 2020 Mar 24;:192186 Authors: Moulin K, Viallon M,...
Latest News

DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations.

Newsemia
Giganti, F; Pecoraro, M; Fierro, D; Campa, R; Del Giudice, F; Punwani, S; Kirkham, A; … Panebianco, V; + view all Giganti, F; Pecoraro, M;...
Biology

Modality Solutions Webinar Replay: Cold Chain Validation Best Practices Including CAR T-cell and ADC Immunotherapies

Newsemia
HOUSTON (PRWEB) November 22, 2019 Modality Solutions, biopharmaceutical cold chain engineering firm, hosted a live webinar covering a step-by-step cold chain validation guide to meet...
Pharma / Biotech

Determination of ADC Concentration by Ligand-Binding Assays.

Newsemia
Related Articles Determination of ADC Concentration by Ligand-Binding Assays. Methods Mol Biol. 2020;2078:361-369 Authors: Chang HP, Shah DK Abstract Total antibody, conjugated antibody or antibody-conjugated...
Latest News

Forbius Announces First Patient Dosed in Phase 2a EGFR-Overexpressing Triple Negative Breast Cancer (TNBC) Trial of AVID100, a Novel, Tumor-Specific Anti-EGFR ADC

Newsemia
AUSTIN, Texas & MONTREAL–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AVID100?src=hash" target="_blank"gt;#AVID100lt;/agt;–Forbius announces first patient dosed in Phase 2a triple negative breast cancer (TNBC) trial of AVID100, a novel, tumor-selective...
Pediatrics

Antibody-Drug Conjugate, from a Growing Class of Highly Potent Anticancer Drugs, Shows Efficacy against Cell Surface Protein in Neuroblastoma

Newsemia
Physician-scientists in the Cancer Center at Children’s Hospital of Philadelphia have developed a preclinical, potent therapy attached to an antibody that targets a surface protein...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World